CHIESI Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHIESI, and what generic alternatives to CHIESI drugs are available?
CHIESI has fifteen approved drugs.
There are forty-two US patents protecting CHIESI drugs.
There are two hundred and thirty patent family members on CHIESI drugs in thirty-seven countries and thirty-eight supplementary protection certificates in seventeen countries.
Summary for CHIESI
International Patents: | 230 |
US Patents: | 42 |
Tradenames: | 16 |
Ingredients: | 10 |
NDAs: | 15 |
Patent Litigation for CHIESI: | See patent lawsuits for CHIESI |
Drugs and US Patents for CHIESI
Expired US Patents for CHIESI
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-005 | Apr 23, 2015 | 5,712,279 | ⤷ Try a Trial |
Chiesi | CARDENE | nicardipine hydrochloride | INJECTABLE;INJECTION | 019734-001 | Jan 30, 1992 | 5,164,405 | ⤷ Try a Trial |
Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-006 | Apr 23, 2015 | 6,492,365 | ⤷ Try a Trial |
Chiesi | ZYFLO CR | zileuton | TABLET, EXTENDED RELEASE;ORAL | 022052-001 | May 30, 2007 | 5,422,123 | ⤷ Try a Trial |
Chiesi | BETHKIS | tobramycin | SOLUTION;INHALATION | 201820-001 | Oct 12, 2012 | 7,696,178 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CHIESI drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 2.5 mg/mL, 10 mL Ampoules | ➤ Subscribe | 2006-12-27 |
➤ Subscribe | Inhalation Solution | 300 mg/4 mL | ➤ Subscribe | 2017-08-31 |
➤ Subscribe | Injection | 0.1 mg/mL, 200 mL and0.2mg/mL, 200 mL | ➤ Subscribe | 2013-06-20 |
➤ Subscribe | Tablets | 500 mg | ➤ Subscribe | 2016-01-29 |
International Patents for CHIESI Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
South Africa | 201008374 | ⤷ Try a Trial |
South Korea | 101814186 | ⤷ Try a Trial |
South Korea | 20130101080 | ⤷ Try a Trial |
Japan | 7246384 | ⤷ Try a Trial |
Israel | 208876 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for CHIESI Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1725234 | 2014C/002 | Belgium | ⤷ Try a Trial | PRODUCT NAME: LOMITAPIDE ET TOUTE FORME THERAPEUTIQUEMENT EQUIVALENTE TELLE QUE PROTEGEE PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/13/851/001 20130805 |
1725234 | 122014000003 | Germany | ⤷ Try a Trial | PRODUCT NAME: LOMITAPID ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON ODER DAS PIPERIDIN-N-OXID DAVON; REGISTRATION NO/DATE: EU/1/13/851/001-003 20130731 |
1725234 | 2013/063 | Ireland | ⤷ Try a Trial | PRODUCT NAME: LOMITAPIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/13/851/001-003 20130731 |
1007094 | 15C0060 | France | ⤷ Try a Trial | PRODUCT NAME: CANGRELOR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,NOTAMMENT UN SEL TETRASODIQUE; REGISTRATION NO/DATE: EU/1/15/994/001 20150323 |
1725234 | 300634 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: LOMITAPIDE OF HET PIPERIDINE N-OXIDE DAARVAN, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/13/851/001-003 20130805 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.